101 related articles for article (PubMed ID: 1982269)
21. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements.
Hasegawa M; Adachi K; Nakamura S; Sato M; Waddington JL; Koshikawa N
Eur J Pharmacol; 2001 Jul; 423(2-3):171-8. PubMed ID: 11448482
[TBL] [Abstract][Full Text] [Related]
22. Proconvulsant effect of SKF 38393 mediated by nigral D1 receptors.
al-Tajir G; Starr MS; Starr BS
Eur J Pharmacol; 1990 Jul; 182(2):245-51. PubMed ID: 2204536
[TBL] [Abstract][Full Text] [Related]
23. Effects of (+)-4-propyl-9-hydroxynaphthoxazine on midbrain dopamine neurons: an electrophysiological study.
Kelland MD; Freeman AS; LeWitt PA; Chiodo LA
J Pharmacol Exp Ther; 1990 Oct; 255(1):276-84. PubMed ID: 1976800
[TBL] [Abstract][Full Text] [Related]
24. Effects of dopamine agonists on excitatory inputs to nucleus accumbens neurons from the amygdala: modulatory actions of cholecystokinin.
Liang RZ; Wu M; Yim CC; Mogenson GJ
Brain Res; 1991 Jul; 554(1-2):85-94. PubMed ID: 1681991
[TBL] [Abstract][Full Text] [Related]
25. Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain.
Kelly E; Nahorski SR
Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):508-12. PubMed ID: 2441268
[TBL] [Abstract][Full Text] [Related]
26. Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouse.
Burke K; Chandler CJ; Starr BS; Starr MS
Pharmacol Biochem Behav; 1990 Aug; 36(4):729-33. PubMed ID: 1977176
[TBL] [Abstract][Full Text] [Related]
27. Disordered dopamine neurotransmission in the striatum of rats undergoing pilocarpine-induced generalized seizures, as revealed by microdialysis.
al-Tajir G; Starr MS
J Neural Transm Park Dis Dement Sect; 1993; 5(2):89-100. PubMed ID: 8101446
[TBL] [Abstract][Full Text] [Related]
28. Effect of continuous exposure to selective D1 and D2 dopaminergic agonists on rotational behavior in supersensitive mice.
Winkler JD; Weiss B
J Pharmacol Exp Ther; 1989 May; 249(2):507-16. PubMed ID: 2566677
[TBL] [Abstract][Full Text] [Related]
29. D1 receptors function to inhibit the activation of tuberoinfundibular dopamine neurons.
Berry SA; Gudelsky GA
J Pharmacol Exp Ther; 1990 Aug; 254(2):677-82. PubMed ID: 1974647
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
Engber TM; Marin C; Susel Z; Chase TN
Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
[TBL] [Abstract][Full Text] [Related]
31. Hemispheric asymmetry in behavioral response to D1 and D2 receptor agonists in the nucleus accumbens.
Belcheva I; Bryer JB; Starkstein SE; Honig M; Moran TH; Robinson RG
Brain Res; 1990 Nov; 533(2):286-91. PubMed ID: 1981170
[TBL] [Abstract][Full Text] [Related]
32. Selective blockade of dopamine D-1 receptor by SCH 23390 affects dopamine agonist binding to 3H-spiperone labeled D-2 receptors in rat striatum.
Zhang X; Segawa T
Jpn J Pharmacol; 1989 Jul; 50(3):333-45. PubMed ID: 2569545
[TBL] [Abstract][Full Text] [Related]
33. SKF 38393 potentiates yawning induced by LY 171555: further evidence against the autoreceptor hypothesis of yawning.
Spina L; Longoni R; Mulas A; Di Chiara G
Psychopharmacology (Berl); 1989; 98(4):567-8. PubMed ID: 2570436
[TBL] [Abstract][Full Text] [Related]
34. Dopamine D1 receptor modulation of pilocarpine-induced convulsions.
Barone P; Parashos SA; Palma V; Marin C; Campanella G; Chase TN
Neuroscience; 1990; 34(1):209-17. PubMed ID: 2139189
[TBL] [Abstract][Full Text] [Related]
35. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
Giorgi O; Biggio G
Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data.
Stamford JA; Kruk ZL; Millar J
Br J Pharmacol; 1991 Jan; 102(1):45-50. PubMed ID: 1675147
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of D2-receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation.
Stoof JC; Verheijden PF; Leysen JE
Brain Res; 1987 Oct; 423(1-2):364-8. PubMed ID: 2823991
[TBL] [Abstract][Full Text] [Related]
38. Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [Met5]- and [Leu5]-enkephalin and neurotensin content in the rat.
Taylor MD; de Ceballos ML; Jenner P; Marsden CD
Biochem Pharmacol; 1991 May; 41(9):1385-91. PubMed ID: 1673340
[TBL] [Abstract][Full Text] [Related]
39. Ventral pallidal neuronal responses to dopamine receptor stimulation in the nucleus accumbens.
Yang CR; Mogenson GJ
Brain Res; 1989 Jun; 489(2):237-46. PubMed ID: 2568154
[TBL] [Abstract][Full Text] [Related]
40. Contribution of the amygdala and nucleus accumbens to ventral pallidal responses to dopamine agonists.
Napier TC
Synapse; 1992 Feb; 10(2):110-9. PubMed ID: 1350111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
